Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicine company ...

Researchers from Agency for Science, Technology and Research in Singapore recently published a review article exploring how ...

Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.

Home > Pressemitteilung: New solutions for the RNA medicine of ... At the RNApp graduate school, young researchers are working to make RNA-based drugs safer and more effective.

Arcturus Therapeutics Holdings has won U.S. Food and Drug Administration fast-track designation for its ARCT-2304 pandemic flu vaccine candidate.

Plus: Eagle Venture Fund raises $18 million to combat human trafficking, Korea-based NECOA launches first home goods showroom ...

Learn more about whether Moderna, Inc. or Roivant Sciences Ltd. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Moderna, Inc. or Zai Lab Limited is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

CureVac (CVAC) has reported its fourth quarter 2024 financial results, generating mixed reactions from investors as the company balances ...

CDMO, AGC Biologics, announced a strategic decision about the large-scale single-use technology it will use at its new ...

S&P Global expects inflation to remain closer to 3.0% in 2025 as tariffs result in higher prices along the domestic supply ...